EPS Corporation was named one of the “Top 10 Medical Affairs Services Providers in APAC 2025”
January 17, 2025
EPS will be exhibiting at the Outsourcing in Clinical Trials West Coast 2025 in Burlingame, CA
2024
October 23, 2024
Whitepaper Released: Vol.1-Pharmaceutical Regulations in Japan
August 9, 2024
Notice on Reorganization
May 15, 2024
EPS will be exhibiting at the 2024 DIA Annual Meeting in San Diego, CA
May 9, 2024
【Group News】EPS Holdings, Suzuken Group, and Bushu Pharmaceuticals Sign Partnership Agreement to Support the Introduction of Unapproved Drugs (Drug Loss Products) into the Japanese Market
May 8, 2024
EPS will be exhibiting at the 2024 BIO International Convention in San Diego, CA
April 12, 2024
EPS' viewpoint was published in MedTech Outlook APAC.
March 21, 2024
EPNextS Group will collaborate with Frontage Laboratories, Inc. for Early Phase Clinical Trial and Clinical Site Management in the United States to Improve “Drug Lag” and “Drug Loss” Issues in Japan.
January 16, 2024
EPS Corporation was awarded as one of the Top 10 Companies of “Regenerative Medicine Solutions Providers in APAC 2024”
2023
September 20, 2023
Our employee YAMAMOTO Mayumi will speak at DIA Asia
September 20, 2023
EPS Corporation was selected as a finalist in the “Best CRO/CDMO” category of the “Citeline Pharma Intelligence Awards Japan 2023”.
September 6, 2023
EPS will be exhibiting at the Outsourcing In Clinical Trials Southern California 2023 in San Diego, CA
July 6, 2023
EPS Supported Important Japan-led International Investigator-Initiated HR+/HER2- Breast Cancer Study in Asia Pacific
May 6, 2023
EPS will be exhibiting at the 2023 DIA Annual Meeting in Boston, MA
May 1, 2023
【Webinar LIVE】Clinical information in Korea（Regurlatory Affairs and Clinical Trials in Korea）
April 14, 2023
EPS is sponsoring the “Biotech Company of the Year” category of the Citeline Pharma
Intelligence Awards Japan 2023 (Jump to EPS Holdings website)
2022
December 20, 2022
PharmaSUG Single Day Event Tokyo, Japan
September 5, 2022
EPS will be exhibiting at the 2022 DIA CHINA Annual Meeting in Suzhou
September 1, 2022
EPS International Holdings Co.,Ltd. was merged with EPS Corporation
2022
July 11, 2022
Post-Launch role of pharmaceutical products The 7th of 7 Symposia
July 4, 2022
EP-SOGO and EPS International Announce Reorganization of SMO Taiwan
July 4, 2022
EPS Group Forms Strategic Reorganization for CRO Business
June 10, 2022
EPS Holdings will be exhibiting at the DIA2022 Global Annual Meeting held in Chicago.
June 10, 2022
Approval of pharmaceutical products in Japan, the application system and the flow of post-marketing surveillance after approval The 6th of 7 Symposia
May 19, 2022
GCP On-Site Inspection / Document-based Conformity Inspection in Japan; The 5th of 7 Symposia
April 28, 2022
EPS International Announces Changes in Major Shareholders of EPS Korea
April 8, 2022
Clinical Research and Investigator Initiated Clinical Trials in Japan; The 4th of 7 Symposia
March 3, 2022
SMO in Japan; The 3rd of 7 Symposia
February 9, 2022
Clinical Trial Implementation System in Japan; The 2nd of 7 Symposia
2021
December 18, 2021
New Drug Application and Safety Reporting in Japanese Clinical Trials; The 1st of 7 Symposia
October 21, 2021
EPS International announces Executive Leadership Changes
September 16, 2021
Hainan Boao and Hope city Pilot Zone International Medical Policy Promotion Conference
June 23, 2021
EPS Holdings will be exhibiting virtually at the DIA2021 Global Annual Meeting
April 28, 2021
EPS International will have a booth at DIA China 2021
2020
October 20, 2020
EPS International announces Executive Leadership Changes
May 22, 2020
EPS Holdings Announces Acquisition of G&P’s Equity interests
January 22, 2020
EPS International Holdings Co., Ltd. receives “ISO 9001” and “ISO 27001” Certification
January 16, 2020
Regarding a Spoofed e-mail with the subject line of ‘EPS International Korea Ltd’
2019
August 27, 2019
Announcement of Merger
May 23, 2019
Supporting the charity concert “ONCOLO LIVE Remember Girl’s Power!!’19”
Aplil 24, 2019
EPS International and George Clinical Form Strategic Partnership for the Asia-Pacific Region
2017
January 22, 2017
Agreement on Strategic Partnership with 北京格鋭博医薬研発有限公司 (G&P)
2016
October 3, 2016
Partner with a Leader. Let EPSI Work for You.
We will tailor an ideal solution for your specific needs.
Contact Us
Share this page